Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALCALOTIC Study: Metabolic Alcalosis in Decompensated Heart Failure: Prevalence and Influence on Prognosis

NCT04740242 is registered in ClinicalTrials.gov with Spanish Society of Internal Medicine as lead sponsor.

NCT NCT04740242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04740242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALCALOTIC Study: Metabolic Alcalosis in Decompensated Heart Failure: Prevalence and Influence on Prognosis
Lead sponsor
Spanish Society of Internal Medicine
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
September 30, 2021
Enrollment
672 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure, decompensated heart failure, diuretics drug reactions, heart failure, metabolic alkalosis